Diebold Nixdorf Stock Forecast, Price & News

Diebold Nixdorf (NYSE:DBD) Frequently Asked Questions

Is Diebold Nixdorf a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Diebold Nixdorf in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Diebold Nixdorf stock.
View analyst ratings for Diebold Nixdorf or view top-rated stocks.

How has Diebold Nixdorf's stock price been impacted by Coronavirus (COVID-19)?

Diebold Nixdorf's stock was trading at $5.21 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DBD stock has increased by 55.3% and is now trading at $8.09.
View which stocks have been most impacted by COVID-19.

When is Diebold Nixdorf's next earnings date?

Diebold Nixdorf is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Diebold Nixdorf.

How were Diebold Nixdorf's earnings last quarter?

Diebold Nixdorf, Incorporated (NYSE:DBD) posted its quarterly earnings results on Thursday, October, 28th. The technology company reported $0.34 earnings per share for the quarter, missing the consensus estimate of $0.52 by $0.18. The technology company earned $958.20 million during the quarter, compared to the consensus estimate of $1.04 billion. Diebold Nixdorf had a negative net margin of 2.32% and a negative trailing twelve-month return on equity of 10.99%. The business's quarterly revenue was down 3.7% compared to the same quarter last year. During the same period last year, the firm earned $0.28 EPS.
View Diebold Nixdorf's earnings history.

What guidance has Diebold Nixdorf issued on next quarter's earnings?

Diebold Nixdorf issued an update on its FY 2021 earnings guidance on Thursday, November, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.90 billion-$3.95 billion, compared to the consensus revenue estimate of $4.06 billion.

What price target have analysts set for DBD?

4 analysts have issued 1-year price targets for Diebold Nixdorf's stock. Their forecasts range from $14.00 to $20.00. On average, they expect Diebold Nixdorf's share price to reach $16.67 in the next year. This suggests a possible upside of 106.0% from the stock's current price.
View analysts' price targets for Diebold Nixdorf or view top-rated stocks among Wall Street analysts.

Who are Diebold Nixdorf's key executives?

Diebold Nixdorf's management team includes the following people:

• Gerrard B. Schmid, President, Chief Executive Officer & Director
• Olaf Heyden, Chief Operating Officer & Senior Vice President
• Jeffrey L. Rutherford, Senior VP, Chief Financial & Accounting Officer
• Teresa Ostapower, Chief Information Officer
• Elizabeth C. Radigan, Vice President, Chief Ethics & Compliance Officer

What is Gerrard B. Schmid's approval rating as Diebold Nixdorf's CEO?

175 employees have rated Diebold Nixdorf CEO Gerrard B. Schmid on Glassdoor.com. Gerrard B. Schmid has an approval rating of 79% among Diebold Nixdorf's employees.

Who are some of Diebold Nixdorf's key competitors?

Some companies that are related to Diebold Nixdorf include Apple (AAPL), Dell Technologies (DELL), HP (HPQ), NCR (NCR), 3D Systems (DDD), Avid Technology (AVID), Stratasys (SSYS) and Kopin (KOPN).
View all of DBD's competitors.

What other stocks do shareholders of Diebold Nixdorf own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Diebold Nixdorf investors own include AbbVie (ABBV), Chicago Bridge Iron (CBI), Bristol-Myers Squibb (BMY), KKR & Co. Inc. (KKR), Philip Morris International (PM), Vector Group (VGR), Johnson Controls International (JCI), Mattel (MAT), Mondelez International (MDLZ) and Dunkin' Brands Group (DNKN).

What is Diebold Nixdorf's stock symbol?

Diebold Nixdorf trades on the New York Stock Exchange (NYSE) under the ticker symbol "DBD."

Who are Diebold Nixdorf's major shareholders?

Diebold Nixdorf's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.01%), Beach Point Capital Management LP (6.30%), Gamco Investors INC. ET AL (4.74%), Neuberger Berman Group LLC (2.92%), ArrowMark Colorado Holdings LLC (2.02%) and Victory Capital Management Inc. (1.90%). Company insiders that own Diebold Nixdorf stock include Arthur F Anton, Bruce H Besanko, Ellen Costello, Gary G Greenfield, Gerrard Schmid, Jeffrey L Rutherford, Lauren States, Matthew Goldfarb, Olaf Robert Heyden and Phillip R Cox.
View institutional ownership trends for Diebold Nixdorf.

Which major investors are selling Diebold Nixdorf stock?

DBD stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Cambridge Investment Research Advisors Inc., Teacher Retirement System of Texas, Schroder Investment Management Group, Smith Graham & Co. Investment Advisors LP, Lord Abbett & CO. LLC, Citadel Advisors LLC, and Neuberger Berman Group LLC. Company insiders that have sold Diebold Nixdorf company stock in the last year include Gerrard Schmid, and Phillip R Cox.
View insider buying and selling activity for Diebold Nixdorf or view top insider-selling stocks.

Which major investors are buying Diebold Nixdorf stock?

DBD stock was acquired by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, Heartland Advisors Inc., Russell Investments Group Ltd., Brigade Capital Management LP, Natixis, Tudor Investment Corp Et Al, Hotchkis & Wiley Capital Management LLC, and Lapides Asset Management LLC. Company insiders that have bought Diebold Nixdorf stock in the last two years include Arthur F Anton, Bruce H Besanko, Ellen Costello, Gary G Greenfield, Jeffrey L Rutherford, Lauren States, Matthew Goldfarb, and Olaf Robert Heyden.
View insider buying and selling activity for Diebold Nixdorf or or view top insider-buying stocks.

How do I buy shares of Diebold Nixdorf?

Shares of DBD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Diebold Nixdorf's stock price today?

One share of DBD stock can currently be purchased for approximately $8.09.

How much money does Diebold Nixdorf make?

Diebold Nixdorf has a market capitalization of $633.89 million and generates $3.90 billion in revenue each year. The technology company earns $-269.10 million in net income (profit) each year or ($1.18) on an earnings per share basis.

How many employees does Diebold Nixdorf have?

Diebold Nixdorf employs 2,020 workers across the globe.

What is Diebold Nixdorf's official website?

The official website for Diebold Nixdorf is www.dieboldnixdorf.com.

Where are Diebold Nixdorf's headquarters?

Diebold Nixdorf is headquartered at 5995 MAYFAIR RD P.O. BOX 3077, NORTH CANTON OH, 44720.

How can I contact Diebold Nixdorf?

Diebold Nixdorf's mailing address is 5995 MAYFAIR RD P.O. BOX 3077, NORTH CANTON OH, 44720. The technology company can be reached via phone at (330) 490-4000, via email at [email protected], or via fax at 330-490-3794.